MammoMARK® and CorMARK®
BIOPSY SITE IDENTIFIER
Rapid expansion anchors the marker in place for unsurpassed placement accuracy.1
MammoMARK® and CorMARK® Biopsy Site Identifier
Expands Rapidly
The size increases by 300% within 60 seconds, reducing the likelihood of movement when releasing breast compression.1
Provides Clear Ultrasound Visibility
The Increased surface area provides ease of ultrasound visibility at time of deployment.2
Enables Precise Placement
The MammoMARK® and CorMARK® markers help with accurate placement in the biopsy cavity.2
Absorbs Fluid Quickly
The MammoMARK® and CorMARK® markers assist in fluid management by quickly absorbing surrounding fluid.1
Two distinct shapes for better tracking of multiple biopsy sites
SHAPES
- Bowtie
- U-Shape
“The most significant advantage we found with the MammoMARK® is the ability to consistently localize [it] using sonography.”
Krakos et al. Advantages of Using the New MammoMark Percutaneous Breast Biopsy marker – a Large Center Experience.
FREQUENTLY ASKED QUESTIONS
What is the difference between the MammoMARK® and CorMARK® markers?
The applicators are the only difference between the two markers. The CorMARK® markers are the direct puncture applicators and the MammoMARK® markers encompasses all others.
What are the MammoMARK® and CorMARK® markers composed of?
The MammoMARK® and CorMARK® markers are composed of bovine collagen and titanium.
Do the MammoMARK® and CorMARK® markers contain any nickel?
No, the markers do not contain any nickel.
RELATED PRODUCTS
HydroMARK™ Breast Biopsy Site Marker
The exclusive hydrogel technology provides unmatched long-term ultrasound visibility. 3
MammoSTAR® Biopsy Site Marker
The all-natural biopsy marker provides a non-metal marking alternative with a long-lasting beta glucan carrier for unique patient sensitivities.
1. MammoMARK™ Device Test – PRC043442 Rev B, pgs. 2, 5-6: Collagen Expansion
2. Corsi, The American Journal of Surgery (2015) 209, 950-958
3. Sakamoto, N., Fukuma, E., Tsunoda, Y. et al. Evaluation of the dislocation and long-term sonographic detectability of a hydrogel based breast biopsy site marker. Breast Cancer 25, 575–582 (2018). https://doi.org/10.1007/s12282-018-0854-8
Products may not be approved or available in your region. Please check with your local Mammotome representative.